Live News REGULATION FLASH M impact Sep 22, 2026, 06:41 AM UTC European Commission approves AbbVie’s RINVOQ (upadacitinib) AbbVie said the European Commission approved RINVOQ (upadacitinib). ABBV SquawkNews Newsroom